Analysis of the survival of patients positive and negative for the anti-KLHL12 antibodies (Figure 9) showed that presence of these autoantibodies also does not correlate with the length of life or time to liver transplant in PBC patients (p = 0.07). This evidence concerns the gene KLHL12 and primary biliary cholangitis.